Clinical Trials
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Long-Term Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
IRB-HSR# 13557
Service:
Psychiatry
|
Category: Psychiatry/Psychology
Adult Enrollment: Yes
|
Minor Enrollment: No
Primary Investigator: Anita H. Clayton
Contact Information
Contact: Royanne Dell, C.C.R.C.
Phone: 434.243.4655
E-mail: rlb8y@virginia.edu
Clinical Trial Description
Are you 50 or older and suffering from lack of sexual desire?
Dr. Anita Clayton with the UVA Health System Center for Psychiatric
Clinical Research is conducting a research study of an investigational
drug for symptoms of decreased sexual desire. You may qualify if you
are 50 or over and are postmenopausal.
If you qualify and are enrolled, you will receive investigational
drug and regular medical evaluations related to the study at no cost to
you. There are 9 clinic visits over 5 years each clinic visit lasting
2-3 hours.
Compensation:
Compensation is provided
Type Size
